Xenon Pharmaceuticals Inc. <XENE.O>: Wedbush raises target price to $71 from $63
XENE•Related News
Kestrel Q2 FY26 net loss widens to USD 8.1 million; revenue rises 20.12% year-over-year to USD 6.7 million
KG•
Micware announces new equity research coverage from Alphaterra Advisory
MWC•
Allegro MicroSystems holds annual shareholder meeting
ALGM•
Taysha Gene Therapies grants new hire 144,000 RSUs, 92,400 stock options priced at $5.78
TSHA•
HeartCore transfers 51% stake in HeartCore Luvina Vietnam to Luvina Software for JPY 29,000,000
HTCR•